Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 202 participants.
Also called NCT06676696
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 202 participants
- Registry
-
NCT06676696 -
2023-506879-98-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06676696. Randomized; no masking; primary purpose treatment. Start 2024-01-22 (actual); primary completion 2028-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
- Condition
- Renal Failure , Chronic
- Condition
- Graft Failure
- Condition
- Graft Rejection
- Condition
- Allograft
- Condition
- Renal Failure Chronic Requiring Dialysis
- Intervention (Drug)
- Continue low dose calcineurin inhibitor (CNI)
- Intervention (Drug)
- Calcineurin inhibitor withdrawal at 6 months
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Record details
- Record id
cardio:ct-nct06676696- Content hash
43ad773a1fc21c2c20b285289b729ea89836b8bcaf5857c4df14c85c926a8262